RE:RE:RE:What are the next catalysts you askNot to worry Bil there is plenty to be exited about, the Cambium work with genetics could be of the most lucrative. Partnered with Dinafem and adding additional experise and experience, along with operating assets with the acquisitions of BlissCo and Truverra and the on going work with partners like KKE and Medigrow bringing above average product and skills. There is plenty of gain and potential growth in this area and with some of the best in the cannabis industry, on the planet.
The Lot 16, ulrta premium facility producing 'California style' product is the elite end of the menu and selling at much higher price levels than Jean Gee, KK etc....the average consumer is not the target here but many will be on board occasionaly when product is available on the shelf and they get a chance to try it.
Right now FIRE has a 4item menu and all four are the best or equal to the rest on the market and the only thing keeping the SP down is the lack of sales...the current grow area available for production should see 3-5X March 31st sales starting with June 30th sales, due by mid Sept.
Every aspect of FIRE is top shelf, unique in most every way, producing a current menu of the highest demand and they are just getting started....the best is yet to come, along with this new market as it is established over the coming years. FIRE's upside potential is second none now and with the losses that many of the rest look to realize for some time yet, those that own FIRE can expect to be handsomely rewarded for some time to come, JMHO...Opt
Billionaire_2B wrote: Hey Guys, Sorry I had a guy meet with management on a business deal and was trying to pass on info... Seems that he messed up the facts a bit. Upon digging deeper I am not as excited... Goderich is going to be an R&D and focus on selling genetics. I guess there can still be good money in that, but probably hit the balance sheet for another 20M with a long ROI. So Lot 16 can increase production by 10K KG but that won't happen for another year. bummer. oh well I can wait